Posterior reversible encephalopathy syndrome (PRES)

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Vascular insult: Posterior Reversible Encephalopathy Syndrome (PRES) (also known as reversible posterior leukoencephalopathy syndrome) is an acute to subacute neurovascular syndrome characterized by white matter cerebral edema. This condition typically manifests as localized vasogenic edema accumulating around the arteries and arterioles.
• Mechanisms of Blood-Brain Barrier Breakdown: The cerebral edema is driven by endothelial injury or dysfunction that leads to a temporary breakdown of the blood-brain barrier (BBB). Two main theories explain this dysfunction:

    1.  **The Hyperperfusion Theory:** Rapid, severe systemic blood pressure fluctuations (either a rise or a fall) exceed the brain's baseline autoregulatory capacity. This leads to capillary hyperperfusion, increased vascular permeability, and **fluid extravasation (vasogenic edema)** into the interstitium. Elevated blood pressure is observed in approximately 70% of cases, and significant BP fluctuations are common, occurring in 61% to 80% of patients.
    2.  **The Endothelial Dysfunction Theory:** Direct biochemical endothelial injury from circulating cytokines, toxins, or drugs disrupts the blood-brain barrier, triggering fluid leakage and reactive vasospasm. This mechanism is supported by the occurrence of PRES in **normotensive or hypotensive patients (10% to 15% of cases)**, particularly in patients with **severe sepsis, active autoimmune disorders, or those undergoing cytotoxic chemotherapy or immunosuppressive therapy** (especially calcineurin inhibitors like cyclosporine and tacrolimus).

• Posterior Hemispheric Predilection: The classic predilection to the posterior hemispheres of the brain (the parieto-occipital regions) is related to the lower autonomic and sympathetic innervation within the posterior vertebrobasilar circulation. This sparse sympathetic supply results in a significantly decreased autoregulation capacity during acute hemodynamic shifts.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Airway and Ventilatory Support:
• Assess airway patency and immediately intubate patients who are unable to protect their airway or show signs of acute respiratory compromise.
• Maintain normal oxygenation parameters while strictly avoiding hypoxia and hyperoxia, targeting a pulse oximetry window of 94% to 97%.
• Hemodynamic Stabilization and Stepwise BP Control:
• Strict blood pressure control is the mainstay of treatment, requiring continuous hemodynamic monitoring to prevent precipitous BP fluctuations.
• Systolic blood pressure must be reduced in a controlled, gradual manner. The general consensus is to reduce the SBP by no more than 25% within the first hour, with a goal of gradual normalization over the subsequent 24 to 48 hours.
• Avoid overtreating patients whose systolic BP is near normal (130 to 140 mm Hg) to protect against sudden cerebral hypoperfusion and secondary ischemia.
• Administer highly titratable, short-acting intravenous antihypertensive infusions; recommended agents include clevidipine, nicardipine, or labetalol. Avoid corticosteroids, as they are not generally recommended for PRES.
• Acute Seizure Management:
• If active seizures are seen or suspected, administer intravenous anticonvulsants. Long-term antiseizure therapy is generally not required, and no single standard agent is recommended over another.
• Magnesium sulfate is the first choice for treating seizures in patients with PRES, particularly when preeclampsia or eclampsia is suspected or possible.
• Magnesium Sulfate Dosing Protocols:
• Intravenous Route: Administer a 55 to 85 mg/kg (typically 4 to 6 g) IV loading dose over 20 to 30 minutes, followed by a continuous infusion of 30 mg/kg/hour (typically 2 g/hour). Utilize precise weight-based dosing, particularly in smaller pregnant or postpartum patients weighing less than 60 kg.
• Seizure Recurrence: In the event of eclampsia seizure recurrence, an additional IV bolus of 30 mg/kg (typically 2 g) may be given over 5 minutes.
• Intramuscular Rescue: If intravenous access is not immediately available (e.g., during active status epilepticus), administer Magnesium sulfate 70 mg/kg (typically 5 g or 5,000 mg) via deep intramuscular injection in each buttock, for a total dose of 10 g (10,000 mg).
• Strictly monitor serum magnesium levels, renal function, and clinical signs of hypermagnesemia (such as loss of deep tendon reflexes).

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

Top "Can't-Miss" Differential Diagnoses (PRES Mimics)

1. Reversible Cerebral Vasoconstriction Syndrome (RCVS): Presents with recurrent, sudden-onset "thunderclap" headaches. Differentiated from PRES by the absence of diffuse vasogenic edema on neuroimaging and the presence of segmental cerebral vasoconstriction on MRA or CTA.
2. Aneurysmal Subarachnoid Hemorrhage (aSAH): Presents with severe, sudden-onset headache, meningismus, and potential focal cranial nerve palsies. Differentiated by blood in the basal cisterns on CT or red blood cells and xanthochromia in the CSF.
3. Cerebral Venous (Sinus) Thrombosis (CVT): Associated with the peripartum state, presenting with severe headaches, seizures, and altered mental status. Differentiated by a dense sagittal sinus on non-contrast head CT or venous filling defects on CT or MR venography.
4. Meningitis or Encephalitis: Presents with acute encephalopathy, fever, and meningismus. Differentiated by positive CSF parameters (pleocytosis, organisms, or PCR assays) on lumbar puncture.
5. Acute Ischemic Stroke (Posterior Circulation): Presents with acute visual field deficits, cortical blindness, ataxia, or crossed cranial nerve deficits. Differentiated by hyperintense restricted diffusion on brain MRI (DWI and ADC sequences).

Prioritized Diagnostic Workup Strategy

• Immediate Point-of-Care Capillary Glucose: Checked immediately at arrival to rule out hypoglycemia, which is a major stroke and encephalopathy mimic.
• Brain Magnetic Resonance Imaging (MRI): MRI is the diagnostic test of choice to confirm PRES.
• Emergent Non-contrast Head CT: Obtain immediately if MRI is unavailable to detect vasogenic edema and evaluate for associated intracranial hemorrhage, which occurs in 10% to 25% of PRES cases.
• Lumbar Puncture (LP): Indicated only if there is a strong clinical concern for meningitis or encephalitis. Elevated CSF protein is a common finding in PRES, but is highly nonspecific and insensitive.
• Diagnostic Laboratory Panel: Complete blood count (CBC), basic metabolic panel (BMP) to evaluate renal function, and serum magnesium (which is significantly reduced in a large percentage of PRES patients).
• Electroencephalography (EEG): Strongly indicated if subclinical seizures or nonconvulsive status epilepticus (NCSE) are suspected, especially in patients presenting with prolonged postictal states, fluctuating neurologic exams, or altered mental status out of proportion to imaging findings.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

Neuroimaging Diagnostic Checklist

• Brain MRI (T2-weighted / FLAIR sequences): Look for symmetrical, hyperintense white matter signals representing vasogenic edema, classically located in the bilateral parieto-occipital regions. Other cerebral regions (frontal, temporal, brainstem, or cerebellum) can be involved, but typically present as extensions of the classic parieto-occipital lesions.
• Non-contrast Head CT: Symmetrical hypodensities in the posterior parieto-occipital lobes; also vital to screen for associated lobar hemorrhage, mass effect, or intraventricular blood.

Electrocardiography (ECG) Checklist

• 12-Lead ECG: Mandatory to screen for subendocardial ischemia, prolonged corrected QT intervals, or arrhythmias (such as atrial fibrillation or bradycardias) that can be triggered by autonomic instability or severe hypertensive crises.

Bedside Physical Exam Checklist

• Fundoscopy: Evaluate for significant papilledema and hypertensive retinopathy (such as hemorrhages or exudates), indicating severe loss of cerebral vascular autoregulation.
• Ocular Examination: Assess visual acuity, visual fields, extraocular movements, and pupillary reactivity. Patients with cortical blindness from PRES retain intact, briskly reactive pupillary light reflexes bilaterally, which localizes the pathology to the occipital cortex rather than the pre-chiasmal optic pathways.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

High-Risk Clinical Predispositions Checklist

PRES is a clinical-radiological diagnosis of exclusion. The clinician must strongly suspect PRES in any patient presenting with an acute or subacute onset of neurological change in the presence of one or more of the following predisposing risk factors:

• Severe Hypertension / SBP Fluctuations: SBP is elevated in 70% of cases, and significant blood pressure fluctuations occur in 61% to 80%. Hypertension is associated with 53% to 80% of PRES cases.
• Immunosuppressive or Cytotoxic Therapy: Especially calcineurin inhibitors such as cyclosporine and tacrolimus, or recent stem cell/bone marrow transplantation.
• Active Renal Disease: Chronic kidney disease, uremia, or end-stage renal disease.
• Autoimmune Disorders: Present in approximately 50% of cases, and Henoch-Schönlein purpura (HSP).
• Pregnancy-Related Hypertensive Disorders: Active preeclampsia or eclampsia in pregnant (greater than 20 weeks) or postpartum patients (up to 8 weeks).
• Severe Sepsis: Sepsis-mediated endothelial injury can cause PRES even in normotensive or hypotensive patients.

Core Symptom Prevalence Matrix

• Encephalopathy: Present in 80% of patients, ranging from mild confusion to deep coma.
• Tonic-clonic Seizures: Occur in 60% to 75% of patients, with status epilepticus representing a severe complication in 5% to 15%.
• Headache: Present in approximately 50% of patients and is typically dull, diffuse, and gradual, though it occasionally presents as a sudden "thunderclap" headache.
• Visual Disturbances: Occur in 20% to 67% of cases, presenting as decreased visual acuity, visual field cuts, cortical blindness, or visual hallucinations.
• Focal Neurological Deficits: Present in 5% to 15% of cases and typically do not conform to a single vascular territory.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• Deadly Cognitive Traps & Trainee Pitfalls:
• The "Normotensive" Blind Spot: Failing to consider PRES in a normotensive or hypotensive septic patient. Trainees frequently anchor on severe hypertension as a diagnostic prerequisite; however, 10% to 15% of PRES patients are normotensive or hypotensive, where the pathology is driven by cytokine-mediated direct endothelial toxicity.
• Aggressive BP Overtreatment: Precipitous or excessive reduction of blood pressure. Lowering the SBP by more than 25% in the first hour or down to normal/near-normal levels can cause profound cerebral hypoperfusion, converting reversible vasogenic white matter edema into permanent, irreversible cerebral infarction.
• Anchoring on Conversion Disorder: Misclassifying acute cortical blindness or visual hallucinations as psychogenic/conversion because the pupillary reflexes, fundoscopy, and initial head CT are normal. True cortical blindness from bilateral occipital vasogenic edema preserves the pupillary light pathway.
• Premature Prognostic Closure: Documenting a poor neurologic prognosis within the first 24 to 48 hours of presentation. The clinical and radiological findings in PRES are highly reversible, and 75% to 90% of patients recover completely with supportive care and blood pressure control.
• Mandated Board-Exam Critical Actions:
• Check and document a point-of-care capillary glucose immediately on arrival to exclude hypoglycemia.
• Perform and document a meticulous ocular and neurological exam, specifically noting pupillary reactivity, extraocular movements, visual acuity, visual fields, and gait.
• Obtain a pregnancy test for all females of childbearing age presenting with encephalopathy, headache, or seizures.
• Administer Magnesium sulfate immediately as the first-line anticonvulsant for any patient presenting with seizures in the setting of preeclampsia, eclampsia, or suspected PRES.

7. MCQ MASTERCLASS (Written Exam Tips)

• High-Yield "Buzzwords" and Associations:
• "Bilateral parieto-occipital vasogenic edema on T2/FLAIR MRI" is the pathognomonic description for PRES.
• "Cyclosporine or Tacrolimus toxicity" in an immunosuppressed stem cell transplant recipient presenting with a seizure and normal head CT is a classic written exam trigger for PRES.
• "Cortical blindness with briskly reactive pupils" points to bilateral occipital cortex pathology (PRES or posterior stroke) and rules out pre-chiasmal optic nerve pathology.
• "Reduced serum magnesium" is a common laboratory association in patients with PRES.
• Differentiating Distractors:
• Distractor: Recommending an immediate high-dose intravenous corticosteroid (e.g., methylprednisolone) infusion for suspected PRES.
• Correction: Corticosteroids are not generally recommended in the treatment of PRES (unlike MS or vasculitis), and their use should be avoided.
• Distractor: Loading the patient with phenytoin or fosphenytoin for seizures in a pregnant patient with PRES.
• Correction: Phenytoin is less effective than magnesium sulfate and should be avoided in eclampsia or PRES-associated seizures.
• Distractor: Ordering MRA or MRV with gadolinium contrast in a pregnant patient presenting with severe headache and hypertension.
• Correction: Gadolinium-based contrast is relatively contraindicated in pregnancy due to safety concerns; uncontrasted MRI or a non-contrast head CT should be prioritized.
• Distractor: Using sublingual nifedipine for rapid blood pressure lowering.
• Correction: Sublingual nifedipine is contraindicated as it causes rapid, unpredictable drops in SBP that can worsen cerebral hypoperfusion. Use titratable IV infusions (clevidipine, nicardipine, or labetalol) instead.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• Triage and Stabilization Script:
• "This patient presents with an acute onset of neurologic change, encephalopathy, and marked blood pressure elevation. Because this represents an acute neurological emergency, I will place the patient in a monitored resuscitation bay, immediately assess the airway, breathing, and circulation, and obtain a point-of-care capillary glucose to rule out hypoglycemia. I recognize the necessity of excluding critical intracranial pathologies, including intracranial hemorrhage, basilar artery thrombosis, and posterior stroke."
• Mandatory Physical Exam Phrasing:
• "I will perform a focused, comprehensive neurological and ocular examination. I will explicitly document pupillary reactivity, visual acuity, visual fields, and extraocular movements to confirm normal pupillary reflexes, which localizes any visual deficit to the cortex. I will check for signs of meningismus, perform a motor and sensory exam, check deep tendon reflexes to screen for hypermagnesemia, and formally assess their gait if safe."
• Diagnostics and Management Phrasing:
• "Because the patient's airway is secure, I will establish intravenous access and order an emergent non-contrast head CT scan to rule out acute intracranial hemorrhage. I will obtain a comprehensive laboratory panel, including a CBC, metabolic panel, serum magnesium, and a urine pregnancy test. If neuroimaging demonstrates parieto-occipital vasogenic edema, I will make a presumptive diagnosis of PRES."
• "My immediate management will focus on controlled blood pressure reduction. I will avoid sudden fluctuations in BP and target a maximum 25% reduction in SBP within the first hour using a titratable intravenous infusion of clevidipine, nicardipine, or labetalol. If the patient has active seizures, I will administer Magnesium sulfate as a 4 to 6 gram IV loading dose over 20 to 30 minutes, followed by a continuous infusion of 2 grams per hour. I will strictly avoid the use of prophylactic anticonvulsants or empiric corticosteroids."
• Disposition Phrasing:
• "I will consult neurology and admit the patient to a neurocritical care or intensive care unit for continuous hemodynamic monitoring, serial neurological examinations, and advanced diagnostics. I will educate the family that PRES is a highly reversible syndrome with a complete recovery rate of 75% to 90% once the underlying blood pressure and metabolic triggers are optimized, and I will withhold early negative prognostication in the first 24 to 48 hours."